Related references
Note: Only part of the references are listed.Advancing CAR T cell therapy through the use of multidimensional omics data
Jingwen Yang et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
mTORC2 forms iron-clad defense to guard memory
Jordy Saravia et al.
NATURE IMMUNOLOGY (2022)
The kinase complex mTORC2 promotes the longevity of virus-specific memory CD4+ T cells by preventing ferroptosis
Yifei Wang et al.
NATURE IMMUNOLOGY (2022)
Engineered T Cells: CAR T Cell Therapy and Beyond
P. Connor Johnson et al.
CURRENT ONCOLOGY REPORTS (2022)
Dose-dependent thresholds of dexamethasone destabilize CAR T-cell treatment efficacy
Alexander B. Brummer et al.
PLOS COMPUTATIONAL BIOLOGY (2022)
Mathematical Modeling of Tumor and Cancer Stem Cells Treated with CAR-T Therapy and Inhibition of TGF-β
Ellen R. Swanson et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2022)
MicroRNA-mediated metabolic reprogramming of chimeric antigen receptor T cells
Seyed Mohammad Ali Hosseini Rad et al.
IMMUNOLOGY AND CELL BIOLOGY (2022)
Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells
Jingwen Tan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
De novo-designed transmembrane domains tune engineered receptor functions
Assaf Elazar et al.
ELIFE (2022)
Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
Paul A. Valle et al.
PHARMACEUTICS (2022)
Mapping CAR T-Cell Design Space Using Agent-Based Models
Alexis N. Prybutok et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Extracellular signal-regulated kinase (ERK) pathway control of CD8+ T cell differentiation
Marcos P. Damasio et al.
BIOCHEMICAL JOURNAL (2021)
CD137+ T-Cells: Protagonists of the Immunotherapy Revolution
Alessio Ugolini et al.
CANCERS (2021)
Role of the NF-κB system in context-specific tuning of the inflammatory gene response
Meenakshi Chawla et al.
CURRENT OPINION IN IMMUNOLOGY (2021)
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
Huihui Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Modeling CAR T-Cell Therapy with Patient Preconditioning
Katherine Owens et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2021)
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities
Maryam Akhoundi et al.
CELLULAR ONCOLOGY (2021)
Combined 4-1BB and ICOS co-stimulation improves anti-tumor efficacy and persistence of dual anti-CD19/CD20 chimeric antigen receptor T cells
Ying Wang et al.
CYTOTHERAPY (2021)
CARTmath-A Mathematical Model of CAR-T Immunotherapy in Preclinical Studies of Hematological Cancers
Luciana R. C. Barros et al.
CANCERS (2021)
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model
Anna Mueller-Schoell et al.
CANCERS (2021)
Quantifying the limits of CAR T-cell delivery in mice and men
Liam V. Brown et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2021)
CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function
Justin C. Boucher et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Transmembrane domain-mediated Lck association underlies bystander and costimulatory ICOS signaling
Zurong Wan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells
Chuang Sun et al.
CANCER CELL (2020)
Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach
Anat Globerson Levin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Dissecting the Tumor-Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach
Gregory M. Chen et al.
CLINICAL CANCER RESEARCH (2020)
Vav2 lacks Ca2+ entry-promoting scaffolding functions unique to Vav1 and inhibits T cell activation via Cdc42
Michael A. Fray et al.
JOURNAL OF CELL SCIENCE (2020)
Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data
Prativa Sahoo et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2020)
Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model
Aman P. Singh et al.
MABS (2020)
Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
Sonia Guedan et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling
Benjamin Philipson et al.
SCIENCE SIGNALING (2020)
Tuning the Antigen Density Requirement for CAR T-cell Activity
Robbie G. Majzner et al.
CANCER DISCOVERY (2020)
Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy
Wentao Li et al.
IMMUNITY (2020)
A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq
Angela C. Boroughs et al.
MOLECULAR THERAPY (2020)
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function
Benjamin Salzer et al.
NATURE COMMUNICATIONS (2020)
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Ahmet Yilmaz et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Ras-Mediated Activation of the Raf Family K nases
Elizabeth M. Terrell et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Principles of adoptive T cell therapy in cancer
Ozcan Met et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Alternative ZAP70-p38 signals prime a classical p38 pathway through LAT and SOS to support regulatory T cell differentiation
Jesse E. Jun et al.
SCIENCE SIGNALING (2019)
Akt3-Mediated Protection Against Inflammatory Demyelinating Disease
Juwen C. DuBois et al.
FRONTIERS IN IMMUNOLOGY (2019)
Bridging the Gap: Modulatory Roles of the Grb2-Family Adaptor, Gads, in Cellular and Allergic Immune Responses
Deborah Yablonski
FRONTIERS IN IMMUNOLOGY (2019)
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts
Carter M. Suryadevara et al.
CLINICAL CANCER RESEARCH (2019)
Chimeric Antigen Receptor T Cells: A Race to Revolutionize Cancer Therapy
Marion Subklewe et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains
Daniel T. Harris et al.
JOURNAL OF IMMUNOLOGY (2018)
Preclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy
Elizabeth Louise Siegler et al.
HUMAN GENE THERAPY (2018)
OX40L induces helper T cell differentiation during cell immunity of asthma through PI3K/AKT and P38 MAPK signaling pathway
Li Huang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Computational Model of Chimeric Antigen Receptors Explains Site-Specific Phosphorylation Kinetics
Jennifer A. Rohrs et al.
BIOPHYSICAL JOURNAL (2018)
Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
Alexander I. Salter et al.
SCIENCE SIGNALING (2018)
CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs
Juan M. Zapata et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
Andrew Paul et al.
CELLS (2018)
mTOR Regulation of Glycolytic Metabolism in T Cells
Robert J. Salmond
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
4-1BB-Costimulated CAR-Mediated Non-Canonical NF-Kb Signaling Enhances CAR T Cell Survival and Suppresses Bim Expression
Michael C. Milone et al.
BLOOD (2018)
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Sonia Guedan et al.
JCI INSIGHT (2018)
Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
Wenpeng Li et al.
HUMAN GENE THERAPY (2017)
The ClusPro web server for protein-protein docking
Dima Kozakov et al.
NATURE PROTOCOLS (2017)
CAR T-cell immunotherapy of MET-expressing malignant mesothelioma
Thivyan Thayaparan et al.
ONCOIMMUNOLOGY (2017)
IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer
Elzbieta Kania et al.
FRONTIERS IN ONCOLOGY (2017)
The cytotoxic T cell proteome and its shaping by the kinase mTOR
Jens L. Hukelmann et al.
NATURE IMMUNOLOGY (2016)
The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies
Tien Dung Nguyen et al.
JOURNAL OF PROTEOMICS (2016)
Inducible costimulator (ICOS) potentiates TCR-induced calcium flux by augmenting PLCγ1 activation and actin remodeling
Julien Leconte et al.
MOLECULAR IMMUNOLOGY (2016)
A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1
Christophe Pedros et al.
NATURE IMMUNOLOGY (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
T-Cell-Specific Deletion of Map3k1 Reveals the Critical Role for Mekk1 and Jnks in Cdkn1b-Dependent Proliferative Expansion
Tesha Suddason et al.
CELL REPORTS (2016)
ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?
Roser Busca et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
TRUCKs: the fourth generation of CARs
Markus Chmielewski et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
H. Almasbak et al.
GENE THERAPY (2015)
TCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes
Youg Raj Thaker et al.
IMMUNOLOGY LETTERS (2015)
CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology
Pablo Engel et al.
JOURNAL OF IMMUNOLOGY (2015)
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Adrienne H. Long et al.
NATURE MEDICINE (2015)
STORE-OPERATED CALCIUM CHANNELS
Murali Prakriya et al.
PHYSIOLOGICAL REVIEWS (2015)
Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor
Ruijun Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Engineering CAR-T cells: Design concepts
Shivani Srivastava et al.
TRENDS IN IMMUNOLOGY (2015)
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Jiayi Yu et al.
NATURE COMMUNICATIONS (2015)
PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex
Pengda Liu et al.
CANCER DISCOVERY (2015)
Akt1 and-2 inhibition diminishes terminal differentiation and enhances central memory CD8+ T-cell proliferation and survival
Rasha Abu Eid et al.
ONCOIMMUNOLOGY (2015)
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
Sonia Guedan et al.
BLOOD (2014)
The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function
Andrew N. Macintyre et al.
CELL METABOLISM (2014)
The IκB kinase complex in NF-κB regulation and beyond
Michael Hinz et al.
EMBO REPORTS (2014)
Effect of immunotherapy on the response of TICLs to solid tumour invasion
Hermane Mambili-Mamboundou et al.
MATHEMATICAL BIOSCIENCES (2014)
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
Liang-Chuan S. Wang et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
Chan-Juan Shen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Conditional Deletion of PTEN in Peripheral T Cells Augments TCR-Mediated Activation but Does Not Abrogate CD28 Dependency or Prevent Anergy Induction
Frederick L. Locke et al.
JOURNAL OF IMMUNOLOGY (2013)
Phosphatidylinositol 4-Phosphate 5-Kinase a Activation Critically Contributes to CD28-Dependent Signaling Responses
Michela Muscolini et al.
JOURNAL OF IMMUNOLOGY (2013)
T Cell Costimulation with Anti-CD137 Monoclonal Antibodies Is Mediated by K63-Polyubiquitin-Dependent Signals from Endosomes
Ivan Martinez-Forero et al.
JOURNAL OF IMMUNOLOGY (2013)
Leukocyte-specific protein 1 links TNF receptor-associated factor 1 to survival signaling downstream of 4-1BB in T cells
Laurent Sabbagh et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Young T cells age during a redirected anti-tumor attack: chimeric antigen receptor-provided dual costimulation is half the battle
Andreas A. Hombach et al.
FRONTIERS IN IMMUNOLOGY (2013)
Evasion of tumours from the control of the immune system: consequences of brief encounters
Mohannad Al-Tameemi et al.
BIOLOGY DIRECT (2012)
Ubiquitination in signaling to and activation of IKK
Zhijian J. Chen
IMMUNOLOGICAL REVIEWS (2012)
Opposing Roles for TRAF1 in the Alternative versus Classical NF-κB Pathway in T Cells
Ann J. McPherson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
PI3K-PKB/Akt Pathway
Brian A. Hemmings et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors
Noah Isakov et al.
FRONTIERS IN IMMUNOLOGY (2012)
OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4+ T cells
Andreas A. Hombach et al.
ONCOIMMUNOLOGY (2012)
Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation
Ludmila Jirmanova et al.
BLOOD (2011)
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
Markus Chmielewski et al.
CANCER RESEARCH (2011)
In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
De-Gang Song et al.
CANCER RESEARCH (2011)
A single NF kappa B system for both canonical and non-canonical signaling
Vincent Feng-Sheng Shih et al.
CELL RESEARCH (2011)
Activation of p38 mitogen-activated protein kinase is critical step for acquisition of effector function in cytokine-activated T cells, but acts as a negative regulator in T cells activated through the T-cell receptor
Ching Li et al.
IMMUNOLOGY (2011)
Costimulation by chimeric antigen receptors revisited: the T cell antitumor response benefits from combined CD28-OX40 signalling
Andreas A. Hombach et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Decreased Diacylglycerol Metabolism Enhances ERK Activation and Augments CD8+ T Cell Functional Responses
Matthew J. Riese et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Evidence for Direct Activation of mTORC2 Kinase Activity by Phosphatidylinositol 3,4,5-Trisphosphate
Xiaoqing Gan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MEKK3 Regulates IFN-γ Production in T Cells through the Rac1/2-Dependent MAPK Cascades
Xiaofang Wang et al.
JOURNAL OF IMMUNOLOGY (2011)
OX40 Complexes with Phosphoinositide 3-Kinase and Protein Kinase B (PKB) To Augment TCR-Dependent PKB Signaling
Takanori So et al.
JOURNAL OF IMMUNOLOGY (2011)
CD28 Costimulation Impairs the Efficacy of a Redirected T-cell Antitumor Attack in the Presence of Regulatory T cells Which Can Be Overcome by Preventing Lck Activation
David M. Kofler et al.
MOLECULAR THERAPY (2011)
Evidence Implicating the Ras Pathway in Multiple CD28 Costimulatory Functions in CD4+ T Cells
Sujit V. Janardhan et al.
PLOS ONE (2011)
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Michael Croft
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
MKK4/SEK1 Is Negatively Regulated through a Feedback Loop Involving the E3 Ubiquitin Ligase Itch
Young-Ho Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
Michael C. Milone et al.
MOLECULAR THERAPY (2009)
The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells
Aurelie T. Bauquet et al.
NATURE IMMUNOLOGY (2009)
The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-κB and activate T cells
Sung-Gyoo Park et al.
NATURE IMMUNOLOGY (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
CD28 stimulation triggers NF-κB activation through the CARMA1-PKCθ-Grb2/Gads axis
Kei Takeda et al.
INTERNATIONAL IMMUNOLOGY (2008)
Roles of MAPK and NF-kappa B in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells
Yong-Hae Son et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Retargeting of human T cells to tumor-associated MUC1: The evolution of a chimeric antigen receptor
Scott Wilkie et al.
JOURNAL OF IMMUNOLOGY (2008)
ICOS ligation recruits the p50α PI3K regulatory subunit to the immunological synapse
Camille Fos et al.
JOURNAL OF IMMUNOLOGY (2008)
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains
Jinjuan Wang et al.
HUMAN GENE THERAPY (2007)
A costimulation-inlitlated signaling pathway regulates NFATc1 transcription in T lymphocytes
Roza I. Nurieva et al.
JOURNAL OF IMMUNOLOGY (2007)
Role of mitogen-activated protein kinase kinase kinases in signal integration
B. D. Cuevas et al.
ONCOGENE (2007)
The nature of systems biology
Frank J. Bruggeman et al.
TRENDS IN MICROBIOLOGY (2007)
A genetic library screen for signaling proteins that interact with phosphorylated T cell costimulatory receptors
Xingxing Zang et al.
GENOMICS (2006)
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα but not S6K1
David A. Guertin et al.
DEVELOPMENTAL CELL (2006)
NF-κB activation:: nondegradative ubiquitination implicates NEMO
Alain Israel
TRENDS IN IMMUNOLOGY (2006)
Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation
Ryosuke Watanabe et al.
JOURNAL OF IMMUNOLOGY (2006)
CD28 and ICOS: Similar or separate costimulators of T cells?
Miranda E. A. T. van Berkel et al.
IMMUNOLOGY LETTERS (2006)
Controlling NF-κB activation in T cells by costimulatory receptors
ML Schmitz et al.
CELL DEATH AND DIFFERENTIATION (2006)
Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment
T So et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells
Francis Dodeller et al.
ARTHRITIS RESEARCH & THERAPY (2006)
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
MA Pulè et al.
MOLECULAR THERAPY (2005)
The ERK cascade - A prototype of MAPK signaling
H Rubinfeld et al.
MOLECULAR BIOTECHNOLOGY (2005)
NFAT proteins: Key regulators of T-cell development and function
F Macian
NATURE REVIEWS IMMUNOLOGY (2005)
Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion
JX Song et al.
IMMUNITY (2005)
The autoimmune suppressor Gadd45α inhibits the T cell alternative p38 activation pathway
JM Salvador et al.
NATURE IMMUNOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Activating p38 MAPK - New tricks for an old kinase
PR Mittelstadt et al.
CELL CYCLE (2005)
Costimulation of CD8 T cell responses by OX40
P Bansal-Pakala et al.
JOURNAL OF IMMUNOLOGY (2004)
GADD45β/GADD45γ and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNγ production in T cells
HB Chi et al.
EMBO JOURNAL (2004)
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
C Imai et al.
LEUKEMIA (2004)
Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells
DC Tsitoura et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The costimulation-regulated duration of PKB activation controls T cell longevity
JX Song et al.
NATURE IMMUNOLOGY (2004)
CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of human T lymphocytes
R Tavano et al.
JOURNAL OF IMMUNOLOGY (2004)
CD3/CD28 costimulation-induced NF-kappa B activation is mediated by recruitment of protein kinase C-theta, Bcl10, and I kappa B kinase beta to the immunological synapse through CARMA1
DH Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Role of T cell costimulation in anti-viral immunity
EM Bertram et al.
SEMINARS IN IMMUNOLOGY (2004)
Activation of resting human primary T cells with chimeric receptors: Costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain
HM Finney et al.
JOURNAL OF IMMUNOLOGY (2004)
Ca2+/calcineurin signalling in cells of the immune system
S Feske et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Transcriptional regulation of Th2 differentiation by inducible costimulator
RI Nurieva et al.
IMMUNITY (2003)
Independent CD28 signaling via VAV and SLP-76:: a model for in trans costimulation
CE Rudd et al.
IMMUNOLOGICAL REVIEWS (2003)
Vav-1 and the IKKα subunit of IκB kinase functionally associate to induce NF-κB activation in response to CD28 engagement
E Piccolella et al.
JOURNAL OF IMMUNOLOGY (2003)
A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS)
Y Harada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A role for NF-κB activation in perforin expression of NK cells upon IL-2 receptor signaling
J Zhou et al.
JOURNAL OF IMMUNOLOGY (2002)
Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding
H Mita et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Transcriptional mechanisms underlying lymphocyte tolerance
F Macián et al.
CELL (2002)
A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in Th cells and regulates their responses
Y Arimura et al.
INTERNATIONAL IMMUNOLOGY (2002)
The CD28 signaling pathway regulates glucose metabolism
KA Frauwirth et al.
IMMUNITY (2002)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
The ups and downs of MEK kinase interactions
C Hagemann et al.
CELLULAR SIGNALLING (2001)
Deficiency of small GTPase Rac2 affects T cell activation
H Yu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation
N Mukerjee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
C Wang et al.
NATURE (2001)
Identification of a phospholipase C-γ1 (PLC-γ1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-γ1 and NFAT
D Yablonski et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
MEKK2 is required for T-cell receptor signals in JNK activation and interleukin-2 gene expression
B Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Requirement for the SLP-76 adaptor CADS in T cell development
J Yoder et al.
SCIENCE (2001)
Mammalian MAP kinase signalling cascades
LF Chang et al.
NATURE (2001)
c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation
K Sabapathy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not T(H)2 cytokines
LP Kane et al.
NATURE IMMUNOLOGY (2001)
Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response
JL Cannons et al.
JOURNAL OF IMMUNOLOGY (2000)
RasGRP essential for mouse thymocyte differentiation and TCR signaling
NA Dower et al.
NATURE IMMUNOLOGY (2000)
The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells
S Feske et al.
JOURNAL OF IMMUNOLOGY (2000)
The CD28-related molecule ICOS is required for effective T cell-dependent immune responses
AJ Coyle et al.
IMMUNITY (2000)
Protein kinase B regulates T lymphocyte survival, nuclear factor κB activation, and Bcl-XL levels in vivo
RG Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
JNK is required for effector T-cell function but not for T-cell activation
C Dong et al.
NATURE (2000)
Cutting edge: Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor
V Ling et al.
JOURNAL OF IMMUNOLOGY (2000)
Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8+ but not CD4+ T cells
C Merritt et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun
F Macian et al.
EMBO JOURNAL (2000)
Share Paper
